Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Cellectar BiosciencesMedicureAerpio PharmaceuticalsInnovate BiopharmaceuticalsVIVUS
SymbolNASDAQ:CLRBOTCMKTS:MCUJFOTCMKTS:ARPONASDAQ:INNTNASDAQ:VVUS
Price Information
Current Price$1.40$1.16$0.51$0.46$0.95
52 Week RangeBuyN/AHoldBuyHold
Analyst Ratings
Consensus RecommendationBuyN/AHoldBuyHold
Consensus Price Target$6.33N/A$1.00$10.00$1.75
% Upside from Price Target352.38% upsideN/A96.46% upside2,062.16% upside84.17% upside
Trade Information
Market Cap$12.22 million$12.53 million$20.66 million$19.11 million$9.80 million
Beta1.290.23N/A-1.741.71
Average Volume175,5672,073273,360590,154734,078
Sales & Book Value
Annual RevenueN/A$22.46 millionN/AN/A$69.76 million
Price / SalesN/A0.56N/AN/A0.15
CashflowN/A$0.21 per shareN/AN/AN/A
Price / CashN/A5.53N/AN/AN/A
Book Value$0.84 per share$4.15 per shareN/A($0.27) per share($6.50) per share
Price / BookN/A0.28N/AN/A-0.15
Profitability
Net Income$-14,090,000.00$3.03 millionN/A$-27,050,000.00$-31,500,000.00
EPS($1.84)N/AN/A($0.98)($2.96)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/A∞∞N/A∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-11.31%N/AN/A-45.16%
Return on Equity (ROE)-134.58%-3.55%N/A-1,557.56%N/A
Return on Assets (ROA)-94.60%-2.87%N/A-234.42%-12.36%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%N/AN/AN/AN/A
Current Ratio4.11%4.20%N/A0.35%0.43%
Quick Ratio4.11%3.59%N/A0.35%0.28%
Ownership Information
Institutional Ownership Percentage14.28%N/A0.37%6.77%15.13%
Insider Ownership Percentage4.26%12.90%38.60%7.90%12.00%
Miscellaneous
Employees7N/AN/A857
Shares Outstanding9.40 million10.80 million40.59 million41.33 million10.65 million
Next Earnings Date5/4/2020 (Estimated)5/4/2020 (Estimated)N/AN/A5/5/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel